580
Participants
Start Date
August 30, 2025
Primary Completion Date
February 28, 2027
Study Completion Date
May 31, 2027
Tirofiban+Oral Dual Antiplatelet Therapy
Tirofiban will use a loading dose, 0.4 μg/kg/min × 30 minutes, then 0.1μg/kg/min infusion for 47.5 hours; sequential Oral Dual Antiplatelet Therapy (Aspirin 100mg qd; Clopidogrel 75mg qd)
Oral Dual Antiplatelet Therapy
Aspirin 100mg qd; Clopidogrel 75mg qd (after first dose of 300mg)
RECRUITING
Second Affiliated Hospital of Soochow University, Suzhou
RECRUITING
Suzhou Municipal Hospital of Anhui Province, Suzhou
RECRUITING
Second Hospital of Hebei Medical University, Shijiazhuang
RECRUITING
Taikang Xian People's Hospital, Zhoukou
RECRUITING
WuYuan County People's Hospital, Bayan Nur
RECRUITING
Huai'an First People's Hospital, Huai'an
RECRUITING
Jiangsu Province (Suqian) Hospital, Suqian
RECRUITING
Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Suzhou
RECRUITING
Changshu No.1 People's Hospital, Suzhou
RECRUITING
First People's Hospital of Kunshan, Suzhou
RECRUITING
Suzhou Ninth People's Hospital, Suzhou
RECRUITING
Suzhou Xiangcheng People's Hospital, Suzhou
RECRUITING
Taicang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou
RECRUITING
Zhangjiagang Hospital of Traditional Chinese Medicine, Suzhou
RECRUITING
Taixing Second People's Hospital, Taizhou
RECRUITING
Nuclear Industry 417 Hospital, Xi'an
RECRUITING
First People's Hospital of Xianyang, Xianyang
RECRUITING
Second Hospital of Tianjin Medical University, Tianjin
Second Affiliated Hospital of Soochow University
OTHER